SCD-044

· Sun Pharmaceutical Industries Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SCD-044, covering 2025-12-30 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis [Phase 2]